University of Hertfordshire

From the same journal

By the same authors

Standard

Choosing Not to Take Phosphate Binders : The Role of Dialysis Patients' Medication Beliefs. / Wileman, Vari; Chilcot, Joseph; Norton, Sam; Hughes, Lyndsay; Wellsted, D.; Farrington, Ken.

In: Nephron Clinical Practice, Vol. 119, No. 3, 2011, p. c205-c213.

Research output: Contribution to journalArticle

Harvard

Wileman, V, Chilcot, J, Norton, S, Hughes, L, Wellsted, D & Farrington, K 2011, 'Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication Beliefs' Nephron Clinical Practice, vol 119, no. 3, pp. c205-c213. DOI: 10.1159/000329106

APA

Wileman, V., Chilcot, J., Norton, S., Hughes, L., Wellsted, D., & Farrington, K. (2011). Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication Beliefs. Nephron Clinical Practice, 119(3), c205-c213. DOI: 10.1159/000329106

Vancouver

Wileman V, Chilcot J, Norton S, Hughes L, Wellsted D, Farrington K. Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication Beliefs. Nephron Clinical Practice. 2011;119(3):c205-c213. Available from, DOI: 10.1159/000329106

Author

Wileman, Vari ; Chilcot, Joseph ; Norton, Sam ; Hughes, Lyndsay ; Wellsted, D. ; Farrington, Ken. / Choosing Not to Take Phosphate Binders : The Role of Dialysis Patients' Medication Beliefs. In: Nephron Clinical Practice. 2011 ; Vol. 119, No. 3. pp. c205-c213

Bibtex

@article{32c7965e8e964c84b667a43d9314c116,
title = "Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication Beliefs",
abstract = "Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5{\%} of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.",
author = "Vari Wileman and Joseph Chilcot and Sam Norton and Lyndsay Hughes and D. Wellsted and Ken Farrington",
note = "Copyright {\circledC} 2011 S. Karger AG, Basel.",
year = "2011",
doi = "10.1159/000329106",
language = "English",
volume = "119",
pages = "c205--c213",
journal = "Nephron Clinical Practice",
issn = "1660-8151",
publisher = "S. Karger AG",
number = "3",

}

RIS

TY - JOUR

T1 - Choosing Not to Take Phosphate Binders

T2 - Nephron Clinical Practice

AU - Wileman,Vari

AU - Chilcot,Joseph

AU - Norton,Sam

AU - Hughes,Lyndsay

AU - Wellsted,D.

AU - Farrington,Ken

N1 - Copyright © 2011 S. Karger AG, Basel.

PY - 2011

Y1 - 2011

N2 - Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.

AB - Objective: Patients with end-stage renal disease (ESRD) receiving haemodialysis are at risk of cardiovascular disease and bone disorders related to high levels of serum phosphate (PO(4)). Phosphate binders are an important treatment; however, non-adherence remains a significant issue. This study investigates whether patients' beliefs about medicines predict intentional non-adherence to phosphate binders. Method: This was a cross-sectional study of ESRD patients (n = 76). Non-adherence was measured in two ways: (1) the self-report Medication Adherence Questionnaire (MAQ) and (2) 3-month average level of serum phosphate. The Beliefs about Medicines questionnaire was used to assess general and specific beliefs towards phosphate medicines. Results: Eleven (14.5% of 76) patients reported being intentionally non-adherent to phosphate binders. Patients' beliefs that phosphate binders were less necessary were significantly associated with intentional self-reported non- adherence. Furthermore, patients with greater concerns about phosphate binders had higher serum phosphate levels. Conclusion: Assessing patient beliefs about medicines is a reliable indicator of intentional non-adherence to treatment with phosphate binders. These findings may help in identifying ways in which adherence rates to phosphate binders can be improved.

U2 - 10.1159/000329106

DO - 10.1159/000329106

M3 - Article

VL - 119

SP - c205-c213

JO - Nephron Clinical Practice

JF - Nephron Clinical Practice

SN - 1660-8151

IS - 3

ER -